Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regencell Bioscience Limited

12.62
-1.4700-10.43%
Post-market: 12.990.3700+2.93%19:59 EDT
Volume:4.85M
Turnover:59.56M
Market Cap:164.22M
PE:-38.17
High:14.68
Open:11.80
Low:9.50
Close:14.09
Loading ...
Oct 25, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Oct 28, 2023

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Oct 31, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jul 26, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 04, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 30, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 15, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 08, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 30, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 23, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Jun 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 11, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Jun 11, 2021

Correspondence

CORRESP [Cover] - Correspondence